Jae-Hung Shieh

Title: The Innovative Contributions of Jae-Hung Shieh in Cancer Treatment

Introduction

Jae-Hung Shieh is a notable inventor based in New York, NY (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. His work focuses on the use of ureidomustine (BO-1055), a promising agent in the fight against various types of cancer.

Latest Patents

Jae-Hung Shieh holds a patent for the "Use of ureidomustine (BO-1055) in cancer treatment." This patent outlines a method for utilizing ureidomustine, a water-soluble NDA cross-linking agent, in treating cancers such as acute myeloid leukemia (ALL), acute B lymphoblastic leukemia (B-ALL), lymphomas, small lung cell carcinoma (SCLC), and sarcomas, among others. His innovative approach has the potential to improve treatment outcomes for patients suffering from these serious conditions.

Career Highlights

Throughout his career, Jae-Hung Shieh has worked with prestigious institutions, including Academia Sinica and Memorial Sloan Kettering Cancer Center. His experience in these renowned organizations has allowed him to collaborate with leading experts in the field of oncology and contribute to groundbreaking research.

Collaborations

Some of Jae-Hung Shieh's notable coworkers include Malcolm A. Moore and Tsann-Long Su. Their collaborative efforts have further advanced the understanding and treatment of cancer, showcasing the importance of teamwork in scientific research.

Conclusion

Jae-Hung Shieh's innovative work in cancer treatment exemplifies the impact of dedicated research and collaboration in the medical field. His patented methods offer hope for improved therapies for various types of cancer, highlighting the importance of innovation in healthcare.